Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Engeli

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
Frontiers in Immunology|October 31, 2024
Exopeptidase combination enhances the degradation of isotopically labelled gluten immunogenic peptides in humansSulayman Mourabit, Sarah Römer, Erin R Bonner, et al.
Journal of Hypertension|January 27, 2012
Aliskiren penetrates adipose and skeletal muscle tissue and reduces renin-angiotensin system activity in obese hypertensive patientsMichael Boschmann, Jürg Nussberger, Stefan Engeli, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 12, 2016
Cross-validated stable-isotope dilution GC-MS and LC-MS/MS assays for monoacylglycerol lipase (MAGL) activity by measuring arachidonic acid released from the endocannabinoid 2-arachidonoyl glycerolArslan Arinc Kayacelebi, Celina Schauerte, Katharina Kling, et al.
Obesity (Silver Spring, Md.)|March 22, 2008
Peripheral endocannabinoid system activity in patients treated with sibutramineStefan Engeli, Karsten Heusser, Jürgen Janke, et al.
Clinical Pharmacology and Therapeutics|May 9, 2006
Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjectsKarsten Heusser, Jens Tank, Andre Diedrich, et al.
Diabetes|October 27, 2006
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesityMatthias Blüher, Stefan Engeli, Nora Klöting, et al.
Journal of Hypertension|August 5, 2016
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and heart failureJens Jordan, Hermann Toplak, Guido Grassi, et al.
ESC Heart Failure|February 27, 2021
Low-fat hypocaloric diet reduces neprilysin in overweight and obese human subjectsChristine Henke, Sven Haufe, Doreen Ziehl, et al.
Scientific Reports|November 13, 2022
Clinical-pharmacological drug information center of Hannover Medical School: experiences and analysis from a tertiary care university hospitalJohannes Heck, Dirk O Stichtenoth, Ruxandra Sabau, et al.
Journal of Hypertension|May 11, 2012
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertensionJens Jordan, Volkan Yumuk, Markus Schlaich, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Frontiers in Immunology|October 31, 2024
Exopeptidase combination enhances the degradation of isotopically labelled gluten immunogenic peptides in humansSulayman Mourabit, Sarah Römer, Erin R Bonner, et al.
Journal of Hypertension|January 27, 2012
Aliskiren penetrates adipose and skeletal muscle tissue and reduces renin-angiotensin system activity in obese hypertensive patientsMichael Boschmann, Jürg Nussberger, Stefan Engeli, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 12, 2016
Cross-validated stable-isotope dilution GC-MS and LC-MS/MS assays for monoacylglycerol lipase (MAGL) activity by measuring arachidonic acid released from the endocannabinoid 2-arachidonoyl glycerolArslan Arinc Kayacelebi, Celina Schauerte, Katharina Kling, et al.
Obesity (Silver Spring, Md.)|March 22, 2008
Peripheral endocannabinoid system activity in patients treated with sibutramineStefan Engeli, Karsten Heusser, Jürgen Janke, et al.
Clinical Pharmacology and Therapeutics|May 9, 2006
Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjectsKarsten Heusser, Jens Tank, Andre Diedrich, et al.
Diabetes|October 27, 2006
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesityMatthias Blüher, Stefan Engeli, Nora Klöting, et al.
Journal of Hypertension|August 5, 2016
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and heart failureJens Jordan, Hermann Toplak, Guido Grassi, et al.
ESC Heart Failure|February 27, 2021
Low-fat hypocaloric diet reduces neprilysin in overweight and obese human subjectsChristine Henke, Sven Haufe, Doreen Ziehl, et al.
Scientific Reports|November 13, 2022
Clinical-pharmacological drug information center of Hannover Medical School: experiences and analysis from a tertiary care university hospitalJohannes Heck, Dirk O Stichtenoth, Ruxandra Sabau, et al.
Journal of Hypertension|May 11, 2012
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertensionJens Jordan, Volkan Yumuk, Markus Schlaich, et al.
Pageof 14